Magnetic resonance spectroscopy. Data analysis for clinical applications

The aim of this thesis is to make quantitative MRS a more valuable and attractive tool for daily clinical routine use. In the first part of this thesis we will give a brief overview of clinical proton MRS, discussing some common clinical MRS problems. In the second part we will focus on developing a standard protocol to confront the accuracy of different MR scanners from different vendors, analyzing water signals with the open source software package jMRUI – v5.0. Then we will discuss some examples of T1, T2 estimation of water and metabolites at the 3T MR scanner of A.O.U. Meyer using the Siemens phantom aimed to quantitation of metabolites concentration. Some examples of quantitation coming from S.G.D. and S.M.N. hospital will be described too. In the final part some examples of in vivo prostate cancer spectroscopic data analysis will be described, illustrating the potential of MRS, the differences between Philips data analysis software and jMRUI-v5.0, and showing the problems in the daily clinical routine acquisitions too. These MRS data have been acquired at Philips Achieva 1.5 T (S.M.N. hospital). As a future development we will describe an interesting application of PMMA and gold nanoparticles to MR, using the know-how coming from biophotonics research at IFAC-CNR.

[1]  M. van der Graaf,et al.  Proton MR spectroscopy of the normal human prostate with an endorectal coil and a double spin‐echo pulse sequence , 1997, Magnetic resonance in medicine.

[2]  Opstad Ks Quantification and pattern recognition of ¹H magnetic resonance brain tumour spectra for automated classification. , 2005 .

[3]  U. Klose In vivo proton spectroscopy in presence of eddy currents , 1990, Magnetic resonance in medicine.

[4]  D. Graveron-Demilly,et al.  Time-domain quantitation of 1H short echo-time signals: background accommodation , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.

[5]  Pravat K Mandal,et al.  In vivo proton magnetic resonance spectroscopic signal processing for the absolute quantitation of brain metabolites. , 2012, European journal of radiology.

[6]  T. Scheenen,et al.  Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T , 2012, Journal of magnetic resonance imaging : JMRI.

[7]  Denis S. Grebenkov,et al.  NMR survey of reflected brownian motion , 2007 .

[8]  Weili Zheng,et al.  Atlas‐based automated positioning of outer volume suppression slices in short‐echo time 3D MR spectroscopic imaging of the human brain , 2011, Magnetic resonance in medicine.

[9]  A H Wilman,et al.  Metabolite‐specific NMR spectroscopy in vivo , 1997, NMR in biomedicine.

[10]  Thomas Hambrock,et al.  In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil. , 2011, European urology.

[11]  Olivier Tillement,et al.  Gold nanoparticles designed for combining dual modality imaging and radiotherapy , 2008 .

[12]  Andrew Z. Wang,et al.  Nanoparticles and their applications in cell and molecular biology. , 2014, Integrative biology : quantitative biosciences from nano to macro.

[13]  G M Bydder,et al.  MR Imaging: Clinical Use of the Inversion Recovery Sequence , 1985, Journal of computer assisted tomography.

[14]  J Hennig,et al.  Coupling effects in volume selective 1H spectroscopy of major brain metabolites , 1991, Magnetic resonance in medicine.

[15]  Katharina Landfester,et al.  Interaction of nanoparticles with cells. , 2009, Biomacromolecules.

[16]  U. Klose,et al.  Reliable detection of macromolecules in single‐volume 1H NMR spectra of the human brain , 2001, Magnetic resonance in medicine.

[17]  W. Perman,et al.  Spatially resolved high resolution spectroscopy by “four-dimensional” NMR , 1983 .

[18]  S. Provencher Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[19]  Xavier Golay,et al.  Scan time reduction in proton magnetic resonance spectroscopic imaging of the human brain , 2001, Magnetic Resonance in Medicine.

[20]  Cosimo Trono,et al.  Intracellular delivery of molecular beacons by PMMA nanoparticles and carbon nanotubes for mRNA sensing , 2013, Photonics West - Biomedical Optics.

[21]  H. Hricak,et al.  Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. , 2007, Radiology.

[22]  Ricardo Otazo,et al.  MR spectroscopic imaging: Principles and recent advances , 2013, Journal of magnetic resonance imaging : JMRI.

[23]  R. Franklin,et al.  Citrate metabolism of normal and malignant prostate epithelial cells. , 1997, Urology.

[24]  A. O. Rodríguez,et al.  Principles of magnetic resonance imaging , 2004 .

[25]  A. A. Maudsley,et al.  Reproducibility of serial whole‐brain MR Spectroscopic Imaging , 2009, NMR in biomedicine.

[26]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[27]  P. Bottomley Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.

[28]  P Boesiger,et al.  Pitfalls in lactate measurements at 3T. , 2006, AJNR. American journal of neuroradiology.

[29]  Luciano Merlini,et al.  Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[30]  Lev Dykman,et al.  Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. , 2011, Chemical Society reviews.

[31]  B. Mueller,et al.  Proton echo‐planar spectroscopic imaging of J‐coupled resonances in human brain at 3 and 4 Tesla , 2007, Magnetic resonance in medicine.

[32]  C Boesch,et al.  Versatile frequency domain fitting using time domain models and prior knowledge , 1998, Magnetic resonance in medicine.

[33]  Michael Garwood,et al.  Solvent Suppression Using Selective Echo Dephasing , 1996 .

[34]  J. Pauly,et al.  Design of symmetric‐sweep spectral‐spatial RF pulses for spectral editing , 2004, Magnetic resonance in medicine.

[35]  P F Renshaw,et al.  In vivo detection of GABA in human brain using a localized double‐quantum filter technique , 1997, Magnetic resonance in medicine.

[36]  John Kurhanewicz,et al.  Quantification of prostate MRSI data by model‐based time domain fitting and frequency domain analysis , 2006, NMR in biomedicine.

[37]  P. Sundgren,et al.  Diffusion tensor imaging of the brain: review of clinical applications , 2004, Neuroradiology.

[38]  D. C. Soares,et al.  Theranostic Nanoparticles: Imaging and Therapy Combined , 2014 .

[39]  T. Scheenen,et al.  Prostate MRI and 3D MR spectroscopy: how we do it. , 2010, AJR. American journal of roentgenology.

[40]  W S Ng,et al.  Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. , 2004, The Journal of urology.

[41]  T. Scheenen,et al.  Role of high‐field MR in studies of localized prostate cancer , 2014, NMR in biomedicine.

[42]  Oded Gonen,et al.  Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. , 2003, Magnetic resonance imaging.

[43]  Olivier Scheidegger,et al.  Optimized quantitative magnetic resonance spectroscopy for clinical routine , 2013, Magnetic resonance in medicine.

[44]  Andrew G. Webb,et al.  Parallel transmit and receive technology in high‐field magnetic resonance neuroimaging , 2010, Int. J. Imaging Syst. Technol..

[45]  S. Mori,et al.  Principles of Diffusion Tensor Imaging and Its Applications to Basic Neuroscience Research , 2006, Neuron.

[46]  J. Kurhanewicz,et al.  Improved water and lipid suppression for 3D PRESS CSI using rf band selective inversion with gradient dephasing (basing) , 1997, Magnetic resonance in medicine.

[47]  Olivier Beuf,et al.  Design of Gold Nanoparticles for Magnetic Resonance Imaging , 2006 .

[48]  Vladimir Torchilin,et al.  Tumor delivery of macromolecular drugs based on the EPR effect. , 2011, Advanced drug delivery reviews.

[49]  K. Uğurbil,et al.  NMR chemical shift imaging in three dimensions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Spraul,et al.  Ultra high field NMR spectroscopic studies on human seminal fluid, seminal vesicle and prostatic secretions. , 1994, Journal of pharmaceutical and biomedical analysis.

[51]  D P Auer,et al.  On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain , 1995, NMR in biomedicine.

[52]  Lin Mei,et al.  Nanotheranostics ˗ Application and Further Development of Nanomedicine Strategies for Advanced Theranostics , 2014, Theranostics.

[53]  A. Heerschap,et al.  Removal of the outer lines of the citrate multiplet in proton magnetic resonance spectra of the prostatic gland by accurate timing of a point-resolved spectroscopy pulse sequence , 1997, Magnetic Resonance Materials in Physics, Biology and Medicine.

[54]  T. Scheenen,et al.  In vivo 1H MR spectroscopic imaging of aggressive prostate cancer: Can we detect lactate? , 2014, Magnetic resonance in medicine.

[55]  Geoffrey D Clarke,et al.  Proton magnetic resonance spectroscopy in the brain: report of AAPM MR Task Group #9. , 2002, Medical physics.

[56]  Abass Alavi,et al.  Emerging role of radiolabeled nanoparticles as an effective diagnostic technique , 2012, EJNMMI Research.

[57]  R. Schipper,et al.  Polyamines and prostatic cancer. , 2003, Biochemical Society transactions.

[58]  Michael Garwood,et al.  Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T , 2005, Magnetic resonance in medicine.

[59]  P. Carroll,et al.  Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. , 2004, Radiology.

[60]  Tingxian Liu,et al.  Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer. , 2014, Nanoscale.

[61]  Francis Vocanson,et al.  Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. , 2008, Journal of the American Chemical Society.

[62]  Guo-Feng Luo,et al.  Therapeutic nanomedicine based on dual-intelligent functionalized gold nanoparticles for cancer imaging and therapy in vivo. , 2013, Biomaterials.

[63]  B J Soher,et al.  Quantitation of automated single‐voxel proton MRS using cerebral water as an internal reference , 1996, Magnetic resonance in medicine.

[64]  H. Huisman,et al.  Standardized Threshold Approach Using Three-Dimensional Proton Magnetic Resonance Spectroscopic Imaging in Prostate Cancer Localization of the Entire Prostate , 2007, Investigative radiology.

[65]  van der Graaf M,et al.  Effect of Cation Binding on the Proton Chemical Shifts and the Spin-Spin Coupling Constant of Citrate , 1996, Journal of magnetic resonance. Series B.

[66]  C. Picu,et al.  NMR relaxation and pulsed-gradient diffusion study of polyethylene nanocomposites. , 2005, The Journal of chemical physics.

[67]  Hui Mao,et al.  Improving the Magnetic Resonance Imaging Contrast and Detection Methods with Engineered Magnetic Nanoparticles , 2012, Theranostics.

[68]  L. Sillerud,et al.  The pH dependence of chemical shift and spin-spin coupling for citrate. , 1994, Journal of magnetic resonance. Series B.

[69]  D. I. Hoult,et al.  Critical factors in the design of sensitive high resolution nuclear magnetic resonance spectrometers , 1975, Proceedings of the Royal Society of London. A. Mathematical and Physical Sciences.

[70]  Teri W. Odom,et al.  High relaxivity Gd(III)-DNA gold nanostars: investigation of shape effects on proton relaxation. , 2015, ACS nano.

[71]  M. van der Graaf,et al.  Human prostate: multisection proton MR spectroscopic imaging with a single spin-echo sequence--preliminary experience. , 1999, Radiology.

[72]  M. Sdika,et al.  Time‐domain semi‐parametric estimation based on a metabolite basis set , 2005, NMR in biomedicine.

[73]  M. van der Graaf,et al.  Echo-time independent signal modulations using PRESS sequences: a new approach to spectral editing of strongly coupled AB spin systems. , 2005, Journal of magnetic resonance.

[74]  Idriss Blakey,et al.  Multimodal polymer nanoparticles with combined 19F magnetic resonance and optical detection for tunable, targeted, multimodal imaging in vivo. , 2014, Journal of the American Chemical Society.

[75]  P. Allen,et al.  Response of metabolites with coupled spins to the STEAM sequence , 2001, Magnetic resonance in medicine.

[76]  Roberto Passariello,et al.  Value of Magnetic Resonance Spectroscopy Imaging and Dynamic Contrast-Enhanced Imaging for Detecting Prostate Cancer Foci in Men With Prior Negative Biopsy , 2010, Clinical Cancer Research.

[77]  T. Scheenen,et al.  Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. , 2007, Radiology.

[78]  A. Wilman,et al.  The response of the strongly coupled AB system of citrate to typical 1H MRS localization sequences. , 1995, Journal of magnetic resonance. Series B.

[79]  J. Kurhanewicz,et al.  1H MR spectroscopy of normal and malignant human prostates in Vivo , 1990 .

[80]  D. Hirst,et al.  Gold nanoparticles as novel agents for cancer therapy. , 2012, The British journal of radiology.

[81]  P. Carroll,et al.  Quantification of choline‐ and ethanolamine‐containing metabolites in human prostate tissues using 1H HR‐MAS total correlation spectroscopy , 2008, Magnetic resonance in medicine.

[82]  K. Kuroda,et al.  A precise and fast temperature mapping using water proton chemical shift , 1995, Magnetic resonance in medicine.

[83]  J Star-Lack,et al.  High spatial resolution 1H‐MRSI and segmented MRI of cortical gray matter and subcortical white matter in three regions of the human brain , 1999, Magnetic resonance in medicine.

[84]  Michael B. Smith,et al.  Central brightening due to constructive interference with, without, and despite dielectric resonance , 2005, Journal of magnetic resonance imaging : JMRI.

[85]  F. Baldini,et al.  Human dermal fibroblasts HDFa can be used as an appropriate healthy control for PMMA nanoparticles-survivin molecular beacon cellular uptake studies. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[86]  P. Jain,et al.  Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. , 2007, Nanomedicine.

[87]  Cosimo Trono,et al.  Complex Nanostructures Based on Oligonucleotide Optical Switches and Nanoparticles for Intracellular mRNA Sensing and Silencing , 2014 .

[88]  S. Provencher Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.

[89]  D. Leibfritz,et al.  A 1H/13C inverse 2D method for the analysis of the polyamines putrescine, spermidine and spermine in cell extracts and biofluids , 1998, NMR in biomedicine.

[90]  Roberto Pini,et al.  Gold Nanoparticles : Engineering Photothermal effects in connective tissues mediated by laser-activated gold nanorods , 2009 .

[91]  Vanhamme,et al.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.

[92]  Brian D. Ross,et al.  Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases , 1999 .

[93]  M. Zerbib,et al.  Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. , 2005, European urology.

[94]  F. Schick,et al.  Localized proton MR spectroscopy of citrate in vitro and of the human prostate in vivo at 1.5 T , 1993, Magnetic resonance in medicine.

[95]  B. Tomanek,et al.  Applications of nanoparticles for MRI cancer diagnosis and therapy , 2013 .

[96]  Chrit T. W. Moonen,et al.  Highly Effective Water Suppression for in vivo proton NMR Spectroscopy (DRYSTEAM) , 1990 .

[97]  Gioacchino Tedeschi,et al.  High Speed 1H Spectroscopic Imaging in Human Brain by Echo Planar Spatial‐Spectral Encoding , 1995, Magnetic resonance in medicine.

[98]  R. Gruetter,et al.  In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time , 1999, Magnetic resonance in medicine.

[99]  P. Carroll,et al.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.

[100]  W.M.M.J. Bovée,et al.  A single-shot localization pulse sequence suited for coils with inhomogeneous RF fields using adiabatic slice-selective RF pulses , 1991 .

[101]  M. Wyss,et al.  Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. , 1992, The Biochemical journal.

[102]  P. Carroll,et al.  Quantitative analysis of prostate metabolites using 1H HR‐MAS spectroscopy , 2006, Magnetic resonance in medicine.

[103]  Klaas Nicolay,et al.  1H MR spectroscopy of the brain: absolute quantification of metabolites. , 2006, Radiology.

[104]  B J Soher,et al.  Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference , 1993, NMR in biomedicine.

[105]  L. R. Jensen,et al.  Peripheral Zone Prostate Cancer Localization by Multiparametric Magnetic Resonance at 3 T: Unbiased Cancer Identification by Matching to Histopathology , 2012, Investigative radiology.

[106]  Taeghwan Hyeon,et al.  Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy. , 2006, Angewandte Chemie.

[107]  D. Graveron-Demilly,et al.  Java-based graphical user interface for the MRUI quantitation package , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.

[108]  J H Duyn,et al.  Multisection proton MR spectroscopic imaging of the brain. , 1993, Radiology.

[109]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[110]  Hao Hong,et al.  Molecular imaging and therapy of cancer with radiolabeled nanoparticles. , 2009, Nano today.

[111]  P. López-Larrubia,et al.  Quantitative 1H MR spectroscopic imaging of the prostate gland using LCModel and a dedicated basis‐set: Correlation with histologic findings , 2011, Magnetic resonance in medicine.

[112]  Jens Frahm,et al.  Regional Age Dependence of Human Brain Metabolites from Infancy to Adulthood as Detected by Quantitative Localized Proton MRS , 1999, Pediatric Research.

[113]  R. Gruetter,et al.  Echo-time independent signal modulations for strongly coupled systems in triple echo localization schemes: an extension of S-PRESS editing. , 2010, Journal of magnetic resonance.

[114]  M. Kattan,et al.  Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. , 2005, Radiology.

[115]  P. Carroll,et al.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.

[116]  M. Moseley,et al.  In vivo MR tractography using diffusion imaging. , 2003, European journal of radiology.

[117]  B. Choe,et al.  Theoretical Evaluation of Magnetization Behavior in PRESS: for Determination of the Spin-Lattice Relaxation Time, T1 , 2002 .

[118]  C Boesch,et al.  Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy , 2002, Magnetic resonance in medicine.

[119]  Sabine Van Huffel,et al.  An automated quantitation of short echo time MRS spectra in an open source software environment: AQSES , 2007, NMR in biomedicine.

[120]  Roger J. Ordidge,et al.  Image-selected in Vivo spectroscopy (ISIS). A new technique for spatially selective nmr spectroscopy , 1986 .

[121]  J. Frahm,et al.  Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. , 1993, Radiology.

[122]  A. Macovski,et al.  Volumetric spectroscopic imaging with spiral‐based k‐space trajectories , 1998, Magnetic resonance in medicine.

[123]  Steren Chabert,et al.  Diffusion signal in magnetic resonance imaging: origin and interpretation in neurosciences. , 2007, Biological research.

[124]  O Henriksen,et al.  In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. , 1993, Magnetic resonance imaging.

[125]  G. Sotgiu,et al.  Sulfonates-PMMA nanoparticles conjugates: a versatile system for multimodal application. , 2012, Bioorganic & medicinal chemistry.

[126]  M. Ratner,et al.  Size dependence of ferromagnetism in gold nanoparticles: Mean field results , 2007 .

[127]  H. Hricak,et al.  Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging , 2000, Magnetic resonance in medicine.

[128]  C Gabriel,et al.  The dielectric properties of biological tissues: I. Literature survey. , 1996, Physics in medicine and biology.

[129]  Y. Assaraf,et al.  Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. , 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[130]  Zenon Starčuk,et al.  Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package , 2009 .

[131]  Roberto Pini,et al.  Size and shape control in the overgrowth of gold nanorods , 2010 .

[132]  S. Blackband,et al.  Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: Zonal and age‐related differences , 1996, Magnetic resonance in medicine.

[133]  Douglas L. Rothman,et al.  In vivo detection and quantification of scalar coupled H NMR resonances , 2001 .

[134]  Katarzyna J Macura,et al.  Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. , 2009, Radiology.

[135]  J. Pauly,et al.  Dualband spectral‐spatial RF pulses for prostate MR spectroscopic imaging , 2001, Magnetic resonance in medicine.

[136]  Dennis W J Klomp,et al.  Optimal timing for in vivo 1H‐MR spectroscopic imaging of the human prostate at 3T , 2005, Magnetic resonance in medicine.

[137]  M W Weiner,et al.  Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging , 2001, Magnetic resonance in medicine.

[138]  JeremyK. Nicholson,et al.  Proton MRS of human prostatic fluid: Correlations between citrate, spermine, and myo‐inositol levels and changes with disease , 1997, The Prostate.

[139]  Cosimo Trono,et al.  Polymethylmethacrylate nanoparticles as carrier of an oligodeoxynucleotide molecular beacon specific for survivin mRNA in A549 human lung adenocarcinoma epithelial cells , 2015, 2015 XVIII AISEM Annual Conference.

[140]  N. deSouza,et al.  The effect of experimental conditions on the detection of spermine in cell extracts and tissues , 2009, NMR in biomedicine.

[141]  H. Lei,et al.  Simultaneous spectral editing for gamma-aminobutyric acid and taurine using double quantum coherence transfer. , 2000, Journal of magnetic resonance.

[142]  Don Haeng Lee,et al.  Photo-cured PMMA/PEI core/shell nanoparticles surface-modified with Gd-DTPA for T1 MR imaging. , 2014, Journal of colloid and interface science.

[143]  P. Boesiger,et al.  Optimizing PRESS localized citrate detection at 3 Tesla , 2005, Magnetic resonance in medicine.

[144]  Yunpeng Huang,et al.  Multifunctional dendrimer-entrapped gold nanoparticles for dual mode CT/MR imaging applications. , 2013, Biomaterials.

[145]  Z L Gokaslan,et al.  Limitations of stereotactic biopsy in the initial management of gliomas. , 2001, Neuro-oncology.

[146]  Jeong Yu Lee,et al.  Optically Traceable Solid Lipid Nanoparticles Loaded with siRNA and Paclitaxel for Synergistic Chemotherapy with In situ Imaging , 2013, Advanced healthcare materials.

[147]  J. Hennig,et al.  Improved sensitivity to overlapping multiplet signals in in vivo proton spectroscopy using a multiecho volume selective (CPRESS) experiment , 1997, Magnetic resonance in medicine.

[148]  Ji-Xin Cheng,et al.  Hyperthermic effects of gold nanorods on tumor cells. , 2007, Nanomedicine.

[149]  B D Ross,et al.  Absolute Quantitation of Water and Metabolites in the Human Brain. I. Compartments and Water , 1993 .

[150]  R. Bammer Basic principles of diffusion-weighted imaging. , 2003, European journal of radiology.

[151]  Mingwu Shen,et al.  Multifunctional dendrimer-entrapped gold nanoparticles modified with RGD peptide for targeted computed tomography/magnetic resonance dual-modal imaging of tumors. , 2015, Analytical chemistry.

[152]  J Kurhanewicz,et al.  Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. , 1995, Urology.

[153]  Ad Bax,et al.  Improved solvent suppression in one-and two-dimensional NMR spectra by convolution of time-domain data , 1989 .

[154]  B. Meier,et al.  Computer Simulations in Magnetic Resonance. An Object-Oriented Programming Approach , 1994 .

[155]  H. Ahn,et al.  Stromal cells of the human prostate: Initial isolation and characterization , 1996, The Prostate.

[156]  V. Zharov,et al.  Photothermal nanodrugs: potential of TNF-gold nanospheres for cancer theranostics , 2013, Scientific Reports.

[157]  Heinz-Peter Schlemmer,et al.  Discriminating Cancer From Noncancer Tissue in the Prostate by 3-Dimensional Proton Magnetic Resonance Spectroscopic Imaging: A Prospective Multicenter Validation Study , 2011, Investigative radiology.

[158]  P. Allen,et al.  Sources of variability in the response of coupled spins to the PRESS sequence and their potential impact on metabolite quantification , 1999, Magnetic resonance in medicine.

[159]  T. Scheenen,et al.  Mapping of prostate cancer by 1H MRSI , 2014, NMR in biomedicine.

[160]  V. Govindaraju,et al.  Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.

[161]  E Lucarelli,et al.  Mesenchymal stem cells as delivery vehicle of porphyrin loaded nanoparticles: effective photoinduced in vitro killing of osteosarcoma. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[162]  P. Barker,et al.  Diffusion magnetic resonance imaging: Its principle and applications , 1999, The Anatomical record.